AHS2: HLA-A2, A28, A9, A203, A210

被引：0

作者：

Ishikawa, Y ^{[1
]}

Tanaka, H ^{[1
]}

Semana, G ^{[1
]}

Tiercy, JM ^{[1
]}

Fan, L ^{[1
]}

Blasczyk, R ^{[1
]}

Maruya, E ^{[1
]}

Tokunaga, K ^{[1
]}

Akaza, T ^{[1
]}

Juji, T ^{[1
]}

机构：

[1] Japanese Red Cross Cent Blood Ctr, Shibuya Ku, Tokyo 150, Japan

来源：

HLA - GENETIC DIVERSITY OF HLA FUNCTIONAL AND MEDICAL IMPLICATION, PROCEEDINGS OF THE TWELFTH INTERNATIONAL HISTOCOMPATIBILITY WORKSHOP AND CONFERENCE (12TH IHWC), VOL I: WORKSHOP | 1997年

关键词：

D O I：

暂无

中图分类号：

Q98 [人类学];

学科分类号：

030303 ;

摘要：

引用

页码：35 / 41

页数：7

共 27 条

[21] Analysis of renal cell cancer tumour antigen carbonic anhydrase 9 specific cytotoxic T lymphocytes from a healthy HLA-A2 donor
Chong, TW
Salio, M
Hermans, IF
Harris, AL
Cerundolo, V
JOURNAL OF UROLOGY, 2005, 173 (04): : 96 - 96
[22] Impact of amino acid substitution at residue 9 of HLA-A2 on the development of acute GVHD in Korean pediatric patients receiving unrelated hematopoietic stem cell transplantation
Hwang, Sang-Hyun
Oh, Heung-Bum
Choi, Sung-Eun
Seo, Jong-Jin
Lee, Jae-Hwan
Cho, Sung-Woo
Chae, Jeong-Min
Heo, Yong-Seok
Chang, Chulhun L.
Lee, Eun-Yup
TRANSPLANT INTERNATIONAL, 2010, 23 (12) : 1216 - 1222
[23] CD8lowCD28- T Cells: A Human CD8 T-Suppressor Subpopulation With Alloantigen Specificity Induced by Soluble HLA-A2 Dimer In Vitro
Wang, Zhigang
Ouyang, Lichen
Liang, Zhihui
Chen, Jun
Yu, Qian
Jeza, Victor Tunje
Gong, Yeli
Shen, Guanxin
Weng, Xiufang
Wu, Xiongwen
CELL TRANSPLANTATION, 2015, 24 (10) : 2129 - 2142
[24] 基于结直肠癌高表达抗原PSG9的HLA-A2/A3限制性CTL表位预测
赵俊伟
高艳锋
祁元明
祁峰
李永欣
安秀丽
肿瘤防治研究, 2010, 37 (01) : 104 - 105
[25] Definition of the HLA-A2 restricted peptides recognized by human CD8+ effector T cells by flow-assisted sorting of the CD8+ CD45RA+ CD28- T cell subpopulation
Höhn, H
Jülch, M
Pilch, H
Kortsik, C
Tully, G
Neukirch, C
Freitag, K
Maeurer, M
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 131 (01): : 102 - 110
[26] On two groups of the form 28:A9\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$2^{8}{:}A_{9}$$\end{document}
Ayoub B. M. Basheer
Jamshid Moori
Afrika Matematika, 2017, 28 (7-8) : 1011 - 1032
[27] Safety and immunogenicity of vaccination with MART-1 (27-35), gp100 (209-217, 210M), and tyrosinase (368-376, 370D) peptides given in-oil-adjuvant with TLR-9 agonist PF-3512676 and GMCSF for HLA-A2+patients with inoperable stage III or stage IV melanoma
Tarhini, Ahmad A.
Leng, Siyang
Schlesselman, James J.
Lin, Yan X.
Gooding, William E.
Moschos, Stergios
Yin, Yan
Sander, Cynthia
Kirkwood, John M.
CANCER RESEARCH, 2011, 71

← 1 2 3 →